MedPath

Assessment of the effects of combination of topical minoxidil, biotin in comparison with topical minoxidil on mild to moderate androgenetic alopecia patients referring to dermatological clinics of Alzahra hospita

Phase 3
Conditions
Androgenetic alopecia.
Androgenic alopecia, unspecified
L64.9
Registration Number
IRCT20200811048371N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Patients with androgenetic alopecia
Patients who have not been treated with finasteride or other anti-androgen therapy for the past 6 months

Exclusion Criteria

Patients with other types of alopecia (such as alopecia areata, telogen effluvium, anagen effluvium, and scarring alopecia)
Receiving systemic treatment for androgenetic alopecia during the last 6 months
History of allergy to minoxidil, biotin

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath